Literature DB >> 28630264

It Is Time to End the Dualistic Short Versus Long Duration of Dual Antiplatelet Therapy Debates.

Glenn N Levine1, Eric R Bates2.   

Abstract

Keywords:  antiplatelet aggregation inhibitors

Mesh：

Substances：

Year:  2017        PMID： 28630264     DOI： 10.1161/CIRCULATIONAHA.117.028497

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis.

Authors:  Thomas A Mavrakanas; Yiannis S Chatzizisis; Karim Gariani; Dean J Kereiakes; Giuseppe Gargiulo; Gérard Helft; Martine Gilard; Fausto Feres; Ricardo A Costa; Marie-Claude Morice; Jean-Louis Georges; Marco Valgimigli; Deepak L Bhatt; Laura Mauri; David M Charytan
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-22       Impact factor: 8.237

2.  Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low-Dose Prasugrel or Clopidogrel.

Authors:  Gabriele Crimi; Nuccia Morici; Maurizio Ferrario; Luca A Ferri; Luigi Piatti; Daniele Grosseto; Michele Cacucci; Alessandro Mandurino Mirizzi; Anna Toso; Federico Piscione; Marco De Carlo; Luigi Raffaele Elia; Bruno Trimarco; Leonardo Bolognese; Francesco M Bovenzi; Giuseppe De Luca; Stefano Savonitto; Stefano De Servi
Journal:  J Am Heart Assoc       Date:  2019-01-22       Impact factor: 5.501

3.  Thrombotic vs. Bleeding Events of Interruption of Dual Antiplatelet Therapy within 12 Months among Patients with Stent-Driven High Ischemic Risk Definition following PCI.

Authors:  Hao-Yu Wang; Bo Xu; Chen-Xi Song; Chang-Dong Guan; Li-Hua Xie; Yan-Yan Zhao; Zhong-Xing Cai; Sheng Yuan; Ke-Fei Dou
Journal:  J Interv Cardiol       Date:  2022-01-13       Impact factor: 2.279

Review 4.  Antiplatelet Therapy in Coronary Artery Disease: A Daunting Dilemma.

Authors:  Surya Chaturvedula; Daniel Diver; Aseem Vashist
Journal:  J Clin Med       Date:  2018-04-09       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.